In addition, the targets Cyclin D1 and Myc promote proliferation; in solid tumors an influence of Stat3 on VEGF expression could also further promote tumor growth and metastasis/tissue invasion through increased angiogenesis, a process of lower relevance for blood cancers. Here, STAT3 is linked to hematopoietic and lymphoid system neoplasm.